Knowing that IFNλ and IFNβ activates the same downstream signaling pathway after receptor engagement involving phosphorylation of STAT1 we stimulated two of our NSCLC cell lines with recombinant IFNλ and IFNβ to evaluate STAT1 phosphorylation. The gene discussed is STAT1; the disease is non-small cell lung carcinoma.